APOE and cardiovascular disorder: In summary, our experimental findings unequivocally highlight the capacity of IGFBP5 overexpression to augment atherosclerotic plaque development in ApoE−/− mice, implicating this protein as a potential therapeutic target for interventions aiming to curb cardiovascular diseases characterized by excessive plaque build-up.